Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic Processes

Cancer is a serious problem in modern medicine, mainly due to the insufficient effectiveness of currently available therapies. There is a particular interest in compounds of natural origin, which can be used in the prophylaxis, as well as in the treatment and support of cancer treatment. One such co...

Full description

Bibliographic Details
Main Authors: Iwona Jarocka-Karpowicz, Agnieszka Markowska
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/10/2901
_version_ 1797534202948747264
author Iwona Jarocka-Karpowicz
Agnieszka Markowska
author_facet Iwona Jarocka-Karpowicz
Agnieszka Markowska
author_sort Iwona Jarocka-Karpowicz
collection DOAJ
description Cancer is a serious problem in modern medicine, mainly due to the insufficient effectiveness of currently available therapies. There is a particular interest in compounds of natural origin, which can be used in the prophylaxis, as well as in the treatment and support of cancer treatment. One such compound is jasmonic acid (3-oxo-2-(pent-2’-enyl)cyclopentane acetic acid; isolated active form: <i>trans</i>-(-)-(3<i>R</i>,7<i>R</i>)- and <i>cis</i>-(+)-(3<i>R</i>,7<i>S</i>)-jasmonic acid) and its derivatives, which, due to their wide range of biological activities, are also proposed as potential therapeutic agents. Therefore, a review of literature data on the biological activity of jasmonates was prepared, with particular emphasis on the mechanisms of jasmonate action in neoplastic diseases. The anti-tumor activity of jasmonate compounds is based on altered cellular ATP levels; induction of re-differentiation through the action of Mitogen Activated Protein Kinases (MAPKs); the induction of the apoptosis by reactive oxygen species. Jasmonates can be used in anti-cancer therapy in combination with other known drugs, such as cisplatin, paclitaxel or doxorubicin, showing a synergistic effect. The structure–activity relationship of novel jasmonate derivatives with anti-tumor, anti-inflammatory and anti-aging effects is also shown.
first_indexed 2024-03-10T11:27:17Z
format Article
id doaj.art-e154e062c82441938bd14d2818571862
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T11:27:17Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-e154e062c82441938bd14d28185718622023-11-21T19:37:28ZengMDPI AGMolecules1420-30492021-05-012610290110.3390/molecules26102901Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic ProcessesIwona Jarocka-Karpowicz0Agnieszka Markowska1Department of Analytical Chemistry, Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, PolandDepartment of Analytical Chemistry, Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, PolandCancer is a serious problem in modern medicine, mainly due to the insufficient effectiveness of currently available therapies. There is a particular interest in compounds of natural origin, which can be used in the prophylaxis, as well as in the treatment and support of cancer treatment. One such compound is jasmonic acid (3-oxo-2-(pent-2’-enyl)cyclopentane acetic acid; isolated active form: <i>trans</i>-(-)-(3<i>R</i>,7<i>R</i>)- and <i>cis</i>-(+)-(3<i>R</i>,7<i>S</i>)-jasmonic acid) and its derivatives, which, due to their wide range of biological activities, are also proposed as potential therapeutic agents. Therefore, a review of literature data on the biological activity of jasmonates was prepared, with particular emphasis on the mechanisms of jasmonate action in neoplastic diseases. The anti-tumor activity of jasmonate compounds is based on altered cellular ATP levels; induction of re-differentiation through the action of Mitogen Activated Protein Kinases (MAPKs); the induction of the apoptosis by reactive oxygen species. Jasmonates can be used in anti-cancer therapy in combination with other known drugs, such as cisplatin, paclitaxel or doxorubicin, showing a synergistic effect. The structure–activity relationship of novel jasmonate derivatives with anti-tumor, anti-inflammatory and anti-aging effects is also shown.https://www.mdpi.com/1420-3049/26/10/2901jasmonic acidanti-cancer drugsstructure–activity relationshipnovel drug
spellingShingle Iwona Jarocka-Karpowicz
Agnieszka Markowska
Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic Processes
Molecules
jasmonic acid
anti-cancer drugs
structure–activity relationship
novel drug
title Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic Processes
title_full Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic Processes
title_fullStr Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic Processes
title_full_unstemmed Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic Processes
title_short Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic Processes
title_sort jasmonate compounds and their derivatives in the regulation of the neoplastic processes
topic jasmonic acid
anti-cancer drugs
structure–activity relationship
novel drug
url https://www.mdpi.com/1420-3049/26/10/2901
work_keys_str_mv AT iwonajarockakarpowicz jasmonatecompoundsandtheirderivativesintheregulationoftheneoplasticprocesses
AT agnieszkamarkowska jasmonatecompoundsandtheirderivativesintheregulationoftheneoplasticprocesses